Tang Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Tang Capital Management’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,366,783	Closed	-$41.9M	–	139
2023 Q4	$41.9M	Buy	9,366,783 +7,566,783	+420%	+$26M	3.87%	5
2023 Q3	$2.68M	Buy	1,800,000 +837,978	+87%	+$1.6M	0.38%	63
2023 Q2	$2.19M	Buy	962,022 +752,422	+359%	+$1.73M	0.32%	68
2023 Q1	$411K	Buy	209,600 +150,000	+252%	+$311K	0.06%	87
2022 Q4	$97.7K	Buy	+59,600	New	+$92.9K	0.01%	87

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Tang Capital Management's LIAN Position: Q1 2024 in Review

Tang Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 9,366,783 shares — an estimated $41.9M sold.

Tang Capital Management first reported a position in LIAN in Q4 2022 and held it in 5 quarters. The position peaked at $41.9M in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Tang Capital Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Tang Capital Management sold 9,366,783 LianBio American Depositary Shares shares in Q1 2024, an estimated $41.9M.
Tang Capital Management first reported a position in LianBio American Depositary Shares in Q4 2022 and held it in 5 quarters.
Tang Capital Management's LianBio American Depositary Shares position peaked at $41.9M in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.